Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Patent tenofovir alafenamide gilead?
Is januvia still on the market?
Guselkumab patent expiration?
When will there be a generic loreev available?
When will generic fiasap insulin be available?

Mometasone (nasonex) manufacturing plant cost?

See the DrugPatentWatch profile for Mometasone

Rough‑and‑ready cost ball‑park for a mometasone (Nasonex) manufacturing facility

Scope Typical capacity Approximate capital cost (USD) Notes
API‑level plant (raw mometasone) 1 – 2 k tonnes per year $5 – 10 M Includes raw‑material synthesis, crystallisation, drying, QC, and a small lab. Designed for GMP compliance.
Finished‑product (inhalation powder) 50 – 200 tpa $10 – 20 M Adds formulation, capsule/powder mixing, spray‑drying, packaging, and a bigger QC lab.
Full‑scale commercial plant 200 – 500 tpa $20 – 40 M Larger equipment, full automation, robust environmental controls, and more extensive documentation infrastructure.

Bottom line – For a small‑to‑medium mometasone plant (a few thousand tonnes per year) you’re looking at an $8–15 million range, while a large‑scale commercial plant pushes toward $25–35 million or more.

Why the numbers vary so much

Factor Impact on cost Typical range
Location Labor, land, utilities, tax incentives $10–$30 M depending on country
Scale Capital‑expenditure per tonne Lower for larger plants, higher for small plants
Automation level Equipment cost, operation cost, QC $3–$10 M extra for full automation
Regulatory environment GMP, environmental permits, audit costs $1–$5 M additional for stringent markets
Raw‑material cost API cost can drive plant design Not a CAPEX figure, but affects throughput
Facility design Single‑use vs. clean‑room, HVAC, safety $2–$8 M depending on clean‑room grade

Steps to refine the estimate

  1. Define production volume – a 1 k tpa plant is very different from a 200 k tpa facility.
  2. Choose a site – land, utilities, and local regulations can shift the cost by 20–30 %.
  3. Select the technology platform – traditional batch synthesis, continuous flow, or a hybrid approach.
  4. Engage a contract‑manufacturing specialist – they can provide a detailed techno‑economic analysis (TEA) and process‑safety assessment.
  5. Plan for quality and regulatory compliance – GMP certification, 21CFR, and FDA/EU guidelines add both upfront and operating costs.

Quick reference for the mometasone API synthesis

Step Approx. cost per kg of API Notes
Raw‑material purchase $10–$20 Depends on supplier and volume
Synthetic steps (multistep) $30–$60 Includes reagents, solvents, catalysts
Purification & crystallisation $20–$40 Requires chromatography or recrystallisation
Drying & packaging $5–$10 Finished‑product grade
Total $65–$130 per kg Rough estimate for a batch plant

Example: A 2 k tpa plant (≈ 2 000 000 kg/yr) would need roughly $130–$260 M worth of API production over a year, but the capital cost to build the plant is the $5–10 M figure above.

Final take‑away

  • Capital cost: $5–40 M, scaling with production volume, automation, and regulatory demands.
  • Operating cost: Roughly $65–$130 per kg of finished API (raw‑material‑heavy).
  • Time to build: 12–24 months from design to first shipment.

These numbers are indicative; a detailed feasibility study and engineering assessment are essential to nail down a precise budget. If you’re seriously planning a mometasone facility, I’d recommend reaching out to a contract‑manufacturing partner or a process‑engineering consultancy that specialises in inhalation drugs. Good luck!



Other Questions About Mometasone :

mometasone furoate 0.1 cream Mometasone expired? Mometasone furoate lotion price? Mometasone inhaler price? Mometasone furoate cream cost? Mometasone spray price? Mometasone furoate expired?